ATE552839T1 - Pharmazeutische verwendung von immunologisch mit diphtherie-toxin korrelierten proteinmolekülen - Google Patents

Pharmazeutische verwendung von immunologisch mit diphtherie-toxin korrelierten proteinmolekülen

Info

Publication number
ATE552839T1
ATE552839T1 AT06766305T AT06766305T ATE552839T1 AT E552839 T1 ATE552839 T1 AT E552839T1 AT 06766305 T AT06766305 T AT 06766305T AT 06766305 T AT06766305 T AT 06766305T AT E552839 T1 ATE552839 T1 AT E552839T1
Authority
AT
Austria
Prior art keywords
correlated
diphtheria toxin
protein molecules
pharmaceutical use
molecules immunologically
Prior art date
Application number
AT06766305T
Other languages
English (en)
Inventor
Silvio Buzzi
Original Assignee
Baroncini Luciana
Buzzi Giorgio
Buzzi Anna Maria
Buzzi Silva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baroncini Luciana, Buzzi Giorgio, Buzzi Anna Maria, Buzzi Silva filed Critical Baroncini Luciana
Application granted granted Critical
Publication of ATE552839T1 publication Critical patent/ATE552839T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06766305T 2006-05-31 2006-05-31 Pharmazeutische verwendung von immunologisch mit diphtherie-toxin korrelierten proteinmolekülen ATE552839T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2006/000409 WO2007138621A1 (en) 2006-05-31 2006-05-31 Pharmaceutical use of protein molecules immunologically correlated to diphtheria toxin

Publications (1)

Publication Number Publication Date
ATE552839T1 true ATE552839T1 (de) 2012-04-15

Family

ID=37708360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06766305T ATE552839T1 (de) 2006-05-31 2006-05-31 Pharmazeutische verwendung von immunologisch mit diphtherie-toxin korrelierten proteinmolekülen

Country Status (8)

Country Link
US (1) US9107880B2 (de)
EP (1) EP2035022B1 (de)
JP (1) JP5155306B2 (de)
CN (1) CN101460180B (de)
AT (1) ATE552839T1 (de)
CA (1) CA2654014A1 (de)
EA (1) EA015863B1 (de)
WO (1) WO2007138621A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2231770T3 (es) * 1993-03-05 2005-05-16 Wyeth Holdings Corporation Nuevos plasmidos para la produccion de proteina crm y toxina difterica.
US7358254B2 (en) * 2001-07-13 2008-04-15 Bristol-Myers Squibb Company Method for treating atherosclerosis employing an aP2 inhibitor and combination
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법

Also Published As

Publication number Publication date
EP2035022A1 (de) 2009-03-18
US20090270319A1 (en) 2009-10-29
EA015863B1 (ru) 2011-12-30
US9107880B2 (en) 2015-08-18
EA200870597A1 (ru) 2009-06-30
EP2035022B1 (de) 2012-04-11
WO2007138621A8 (en) 2009-03-12
JP2009538902A (ja) 2009-11-12
CN101460180A (zh) 2009-06-17
JP5155306B2 (ja) 2013-03-06
CA2654014A1 (en) 2007-12-06
WO2007138621A1 (en) 2007-12-06
CN101460180B (zh) 2012-06-27

Similar Documents

Publication Publication Date Title
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
CY1119102T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεισαυτων
NO20091064L (no) Antistoffer mot IL-17A
BRPI0809583A2 (pt) polipeptídeos fgf-21 modificados e seus usos
EA201301072A1 (ru) Антитела против il-23p19 и их применение
EA200900492A1 (ru) Молекулы антител, которые связываются с il-17a и il-17f
EA200800952A1 (ru) Конъюгаты антитело-лекарство и способы применения
NO20082473L (no) Fremgangsmater, sammensetninger og sett for behandling av medisinske tilstander
NO20082531L (no) Neuropilinantagonister
EP2173377A4 (de) Antikörper-endostatin-fusionsprotein und seine varianten
EA201100923A1 (ru) Антитела человека против тканевого фактора
EA201270761A1 (ru) Белки на основе структурного домена фибронектина, связывающие pcsk9
EA201000644A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
PL2358756T3 (pl) Ludzkie przeciwciała o wysokim powinowactwie wobec pcsk9
EA201000424A1 (ru) Антитела к il-23
EP1844077A4 (de) Dr5-antikörper und deren verwendung
FI20051318A0 (fi) Selluloosapitoisen materiaalin käsittely ja siihen käytettäviä entsyymejä
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
UA107490C2 (uk) TNF-α-ЗВ'ЯЗУВАЛЬНИЙ БІЛОК
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
NO20083066L (no) Antistoffmolekyler med spesifisitet for human-IL-6
EP2136846A4 (de) Therapeutische ziele und moleküle
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
PT1644484E (pt) Células autólogas de indução de auto-tolerância de origem monocítica e sua utilização em preparações farmacêuticas